1. Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany 
S. Böhler, H. Scharnagl, F. Freisinger, T. Stojakovic, H. Glaesmer, J. Klotsche, L. Pieper, D. Pittrow, W. Kirch, H. Schneider, G.K. Stalla, H. Lehnert, A.M. Zeiher, S. Silber, U. Koch, G. Ruf, W. März, H-U. Wittchen 
Atherosclerosis 
Volume 190, Issue 2, Pages (February 2007)
DOI: /j.atherosclerosis
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions

2. Fig. 1 Age-dependent rates of dyslipidemia by NCEP risk class.
Atherosclerosis  , DOI: ( /j.atherosclerosis )
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions

3. Fig. 2
Age-dependent rates for diagnosis, treatment and goal achievement of clinically diagnosed dyslipidemia.
Atherosclerosis  , DOI: ( /j.atherosclerosis )
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions

4. Fig. 3
Type of lipid-lowering medication across NCEP risk classes (as a % of patients with medical treatment).
Atherosclerosis  , DOI: ( /j.atherosclerosis )
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions

5. Fig. 4
Type of lipid-lowering therapy: lipid-lowering (LL) medication, lifestyle intervention, or both for diagnosed dyslipidemias.
Atherosclerosis  , DOI: ( /j.atherosclerosis )
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions